2023
Hadley, L., Karachaliou Prasinou, A., Christensen, H., Ramsay, M. and Trotter, C., 2023. Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK - ERRATUM. Epidemiol Infect, v. 151
Doi: http://doi.org/10.1017/S095026882300105X
Hadley, L., Karachaliou Prasinou, A., Christensen, H., Ramsay, M. and Trotter, C., 2023. Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK. Epidemiol Infect, v. 151
Doi: http://doi.org/10.1017/S0950268823000870
Swedberg, C., Miranda, MEG., Bautista, C., Anderson, D., Basa-Tulio, M., Chng, NR., Cruz, VDD., Kundegorski, M., Maestro, J., Manalo, D., Maniszewska, K., Manzanilla, DR., Mazeri, S., Mellanby, RJ., Pablo-Abarquez, S., Quiambao, B., Telmo, SVM., Trotter, C., Yuson, M. and Hampson, K., 2023. Using Integrated Bite Case Management to estimate the burden of rabies and evaluate surveillance in Oriental Mindoro, Philippines. One Health Imprement Res, v. 3
Doi: http://doi.org/10.20517/ohir.2023.02
Procter, SR., Gonçalves, BP., Paul, P., Chandna, J., Seedat, F., Koukounari, A., Hutubessy, R., Trotter, C., Lawn, JE. and Jit, M., 2023. Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. PLoS Med, v. 20
Doi: http://doi.org/10.1371/journal.pmed.1004068
Silveira, MM., Crespo da Silva, PA., Conrad, NL., Oliveira, TL., Hartwig, DD. and Trotter, C., 2023. Surveillance of invasive meningococcal disease in southern Brazil: considerations of an immunization programme. J Med Microbiol, v. 72
Doi: http://doi.org/10.1099/jmm.0.001658
Tarusikirwa, DF., Blacklaws, B. and Trotter, CL., 2023. Seroprevalence and assessment of public awareness of Brucella spp., Toxoplasma gondii and Chlamydia abortus in small ruminants from selected smallholder commercial farms of Zimbabwe. PLoS One, v. 18
Doi: http://doi.org/10.1371/journal.pone.0287902
Trotter, CL., Alderson, M., Dangor, Z., Ip, M., Le Doare, K., Nakabembe, E., Procter, SR., Sekikubo, M. and Lambach, P., 2023. Vaccine value profile for Group B streptococcus Vaccine,
Doi: http://doi.org/10.1016/j.vaccine.2023.04.024
Cooper, LV., Stuart, JM., Okot, C., Asiedu-Bekoe, F., Afreh, OK., Fernandez, K., Ronveaux, O. and Trotter, CL., 2023. Corrigendum to "Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana" [Vaccine 37(37) (2019) 5657-5663]. Vaccine, v. 41
Doi: http://doi.org/10.1016/j.vaccine.2023.10.074
Giersing, B., Karron, R., Tufet-Bayona, M., Trotter, C., Lambach, P. and Jit, M., 2023. Vaccine Value Profiles. Vaccine, v. 41 Suppl 2
Doi: http://doi.org/10.1016/j.vaccine.2023.06.083
2022
Pollard, AJ., MacDonald, NE., Dubé, E., Lamden, K., Baxter, PD., Suggitt, D., Donovan, H., Gibney, Y., Rappuoli, R., Wright, C., Rodgers, E., Trotter, C., Stuart, J., Blake, N., Glennie, L., Lucidarme, J., Bai, X., Lekshmi, A., Willeton, L., Clark, SA. and Borrow, R., 2022. Presentations at the UK National Immunisation Conference. Hum Vaccin Immunother, v. 18
Doi: http://doi.org/10.1080/21645515.2022.2087411
Toor, J., Li, X., Jit, M., Trotter, CL., Echeverria-Londono, S., Hartner, A-M., Roth, J., Portnoy, A., Abbas, K., Ferguson, NM. and Am Gaythorpe, K., 2022. COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery. Vaccine, v. 40
Doi: http://doi.org/10.1016/j.vaccine.2022.05.074
Chadwick, FJ., Clark, J., Chowdhury, S., Chowdhury, T., Pascall, DJ., Haddou, Y., Andrecka, J., Kundegorski, M., Wilkie, C., Brum, E., Shirin, T., Alamgir, ASM., Rahman, M., Alam, AN., Khan, F., Swallow, B., Mair, FS., Illian, J., Trotter, CL., Hill, DL., Husmeier, D., Matthiopoulos, J., Hampson, K. and Sania, A., 2022. Combining rapid antigen testing and syndromic surveillance improves community-based COVID-19 detection in a low-income country. Nat Commun, v. 13
Doi: http://doi.org/10.1038/s41467-022-30640-w
Gonçalves, BP., Procter, SR., Paul, P., Chandna, J., Lewin, A., Seedat, F., Koukounari, A., Dangor, Z., Leahy, S., Santhanam, S., John, HB., Bramugy, J., Bardají, A., Abubakar, A., Nasambu, C., Libster, R., Sánchez Yanotti, C., Horváth-Puhó, E., Sørensen, HT., van de Beek, D., Bijlsma, MW., Gardner, WM., Kassebaum, N., Trotter, C., Bassat, Q., Madhi, SA., Lambach, P., Jit, M., Lawn, JE., GBS Danish and Dutch collaborative group for long term outcomes, , GBS Low and Middle Income Countries collaborative group for long term outcomes, , GBS Scientific Advisory Group, epidemiological sub-group, and CHAMPS team, , 2022. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health, v. 10
Doi: http://doi.org/10.1016/S2214-109X(22)00093-6
Katz, S., Townsend-Payne, K., Louth, J., Lee-Jones, L., Trotter, C., Dan Dano, I., Borrow, R. and MenAfriCar Consortium, , 2022. Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West Africa. Vaccine, v. 40
Doi: http://doi.org/10.1016/j.vaccine.2022.08.013
Davies, HG., O'Sullivan, CP., Al Janabi, H., Rattue, H., Trotter, C., Giorgakoudi, K., Ramsay, M., Ladhani, S., Lamagni, T., Okike, IO., Le Doare, K. and Heath, PT., 2022. Comparison of Neurodevelopmental Outcomes in Children With Group B Streptococcal Sepsis and Meningitis. Clin Infect Dis, v. 75
Doi: http://doi.org/10.1093/cid/ciac318
McMillan, M., Koehler, AP., Lawrence, A., Sullivan, TR., Bednarz, J., MacLennan, JM., Maiden, MCJ., Ladhani, SN., Ramsay, ME., Trotter, C., Borrow, R., Finn, A., Kahler, CM., Whelan, J., Vadivelu, K., Richmond, PC. and Marshall, HS., 2022. B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis. J Infect Dis, v. 225
Doi: http://doi.org/10.1093/infdis/jiab444
Lawn, JE., Chandna, J., Paul, P., Jit, M., Trotter, C., Lambach, P. and Ter-Meulen, AS., 2022. Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide. Clin Infect Dis, v. 74
Doi: http://doi.org/10.1093/cid/ciab859
Carr, JP., MacLennan, JM., Plested, E., Bratcher, HB., Harrison, OB., Aley, PK., Bray, JE., Camara, S., Rodrigues, CMC., Davis, K., Bartolf, A., Baxter, D., Cameron, JC., Cunningham, R., Faust, SN., Fidler, K., Gowda, R., Heath, PT., Hughes, S., Khajuria, S., Orr, D., Raman, M., Smith, A., Turner, DPJ., Whittaker, E., Williams, CJ., Zipitis, CS., Pollard, AJ., Oliver, J., Morales-Aza, B., Lekshmi, A., Clark, SA., Borrow, R., Christensen, H., Trotter, C., Finn, A., Maiden, MC., Snape, MD. and UKMenCar4 and ‘Be on the TEAM’ Study Collaborators, , 2022. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme. Clin Microbiol Infect, v. 28
Doi: http://doi.org/10.1016/j.cmi.2022.07.004
Ralph, KMI., Bull, K., Trotter, C., Wood, S. and Jones, CE., 2022. Paediatric health-related quality of life in congenital cytomegalovirus. Arch Dis Child,
Doi: http://doi.org/10.1136/archdischild-2022-324007
2021
Kadambari, S., Trotter, CL., Heath, PT., Goldacre, MJ., Pollard, AJ. and Goldacre, R., 2021. Group B Streptococcal Disease in England (1998 - 2017): A Population-based Observational Study. Clin Infect Dis, v. 72
Doi: http://doi.org/10.1093/cid/ciaa1485
Karachaliou Prasinou, A., Conlan, AJK. and Trotter, CL., 2021. Understanding the Role of Duration of Vaccine Protection with MenAfriVac: Simulating Alternative Vaccination Strategies. Microorganisms, v. 9
Doi: http://doi.org/10.3390/microorganisms9020461
Gaythorpe, KA., Abbas, K., Huber, J., Karachaliou, A., Thakkar, N., Woodruff, K., Li, X., Echeverria-Londono, S., VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease, , Ferrari, M., Jackson, ML., McCarthy, K., Perkins, TA., Trotter, C. and Jit, M., 2021. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries. Elife, v. 10
Doi: http://doi.org/10.7554/eLife.67023
Mueller, JE., Seanehia, J., Yaro, S., Trotter, CL., Borrow, R. and Giles-Vernick, T., 2021. Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns. PLoS One, v. 16
Doi: http://doi.org/10.1371/journal.pone.0253263
MacLennan, JM., Rodrigues, CMC., Bratcher, HB., Lekshmi, A., Finn, A., Oliver, J., Wootton, M., Ray, S., Cameron, C., Smith, A., Heath, PT., Bartolf, A., Nolan, T., Hughes, S., Varghese, A., Snape, MD., Sewell, R., Cunningham, R., Stolton, A., Kay, C., Palmer, K., Baxter, D., Suggitt, D., Zipitis, CS., Pemberton, N., Jolley, KA., Bray, JE., Harrison, OB., Ladhani, SN., Pollard, AJ., Borrow, R., Gray, SJ., Trotter, C. and Maiden, MCJ., 2021. Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results. Lancet Infect Dis, v. 21
Doi: http://doi.org/10.1016/S1473-3099(20)30842-2
Toor, J., Echeverria-Londono, S., Li, X., Abbas, K., Carter, ED., Clapham, HE., Clark, A., de Villiers, MJ., Eilertson, K., Ferrari, M., Gamkrelidze, I., Hallett, TB., Hinsley, WR., Hogan, D., Huber, JH., Jackson, ML., Jean, K., Jit, M., Karachaliou, A., Klepac, P., Kraay, A., Lessler, J., Li, X., Lopman, BA., Mengistu, T., Metcalf, CJE., Moore, SM., Nayagam, S., Papadopoulos, T., Perkins, TA., Portnoy, A., Razavi, H., Razavi-Shearer, D., Resch, S., Sanderson, C., Sweet, S., Tam, Y., Tanvir, H., Tran Minh, Q., Trotter, CL., Truelove, SA., Vynnycky, E., Walker, N., Winter, A., Woodruff, K., Ferguson, NM. and Gaythorpe, KA., 2021. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife, v. 10
Doi: http://doi.org/10.7554/eLife.67635
Li, X., Mukandavire, C., Cucunubá, ZM., Echeverria Londono, S., Abbas, K., Clapham, HE., Jit, M., Johnson, HL., Papadopoulos, T., Vynnycky, E., Brisson, M., Carter, ED., Clark, A., de Villiers, MJ., Eilertson, K., Ferrari, MJ., Gamkrelidze, I., Gaythorpe, KAM., Grassly, NC., Hallett, TB., Hinsley, W., Jackson, ML., Jean, K., Karachaliou, A., Klepac, P., Lessler, J., Li, X., Moore, SM., Nayagam, S., Nguyen, DM., Razavi, H., Razavi-Shearer, D., Resch, S., Sanderson, C., Sweet, S., Sy, S., Tam, Y., Tanvir, H., Tran, QM., Trotter, CL., Truelove, S., van Zandvoort, K., Verguet, S., Walker, N., Winter, A., Woodruff, K., Ferguson, NM., Garske, T. and Vaccine Impact Modelling Consortium, , 2021. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet, v. 397
Doi: http://doi.org/10.1016/S0140-6736(20)32657-X
Silveira, MM., Crespo da Silva, PA., Conrad, NL., Oliveira, TL., Hartwig, DD. and Trotter, C., 2021. Surveillance of invasive meningococcal disease in the south of Brazil: considerations of immunization programme. J Med Microbiol, v. 70
Doi: http://doi.org/10.1099/jmm.0.001323
Wright, C., Blake, N., Glennie, L., Smith, V., Bender, R., Kyu, H., Wunrow, HY., Liu, L., Yeung, D., Knoll, MD., Wahl, B., Stuart, JM. and Trotter, C., 2021. The Global Burden of Meningitis in Children: Challenges with Interpreting Global Health Estimates. Microorganisms, v. 9
Doi: http://doi.org/10.3390/microorganisms9020377
2020
Trotter, C., Abela-Ridder, B., Bharti, O., Knopf, L., Léchenne, M., Mindekem, R., Zinsstag, J. and Hampson, K., 2020. Reply to 'Alternative abridged preventive regimens against rabies for children in high endemic countries'. Vaccine, v. 38
Doi: http://doi.org/10.1016/j.vaccine.2020.06.030
Carr, J., Plested, E., Aley, P., Camara, S., Davis, K., MacLennan, JM., Gray, S., Faust, SN., Borrow, R., Christensen, H., Trotter, C., Maiden, MCJ., Finn, A., Snape, MD. and ‘Be on the TEAM’ investigators, , 2020. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents. BMJ Open, v. 10
Doi: http://doi.org/10.1136/bmjopen-2020-037358
Lawrence, H., Pick, H., Baskaran, V., Daniel, P., Rodrigo, C., Ashton, D., Edwards-Pritchard, RC., Sheppard, C., Eletu, SD., Litt, D., Fry, NK., Rose, S., Trotter, C., McKeever, TM. and Lim, WS., 2020. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study. PLoS Med, v. 17
Doi: http://doi.org/10.1371/journal.pmed.1003326
Pick, H., Daniel, P., Rodrigo, C., Bewick, T., Ashton, D., Lawrence, H., Baskaran, V., Edwards-Pritchard, RC., Sheppard, C., Eletu, SD., Rose, S., Litt, D., Fry, NK., Ladhani, S., Chand, M., Trotter, C., McKeever, TM. and Lim, WS., 2020. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18. Thorax, v. 75
Doi: http://doi.org/10.1136/thoraxjnl-2019-213725
Lasseter, G., Al-Janabi, H., Trotter, CL., Carroll, FE. and Christensen, H., 2020. Understanding the role of peace of mind in childhood vaccination: A qualitative study with members of the general public. Vaccine, v. 38
Doi: http://doi.org/10.1016/j.vaccine.2019.12.009
Brioschi, V., Rutherford, L., Newell, K., Trotter, C. and Arthurs, GI., 2020. Computed Tomographic Assessment of Block Recession Trochleoplasty and Partial Parasagittal Patellectomy in Cats. Vet Comp Orthop Traumatol, v. 33
Doi: http://doi.org/10.1055/s-0039-3400313
Marshall, HS., McMillan, M., Koehler, AP., Lawrence, A., Sullivan, TR., MacLennan, JM., Maiden, MCJ., Ladhani, SN., Ramsay, ME., Trotter, C., Borrow, R., Finn, A., Kahler, CM., Whelan, J., Vadivelu, K. and Richmond, P., 2020. Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia. N Engl J Med, v. 382
Doi: http://doi.org/10.1056/NEJMoa1900236
Ahmed, N., Giorgakoudi, K., Usuf, E., Okomo, U., Clarke, E., Kampmann, B., Le Doare, K. and Trotter, C., 2020. Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia. Vaccine, v. 38
Doi: http://doi.org/10.1016/j.vaccine.2020.02.071
Serra, L., Presa, J., Christensen, H. and Trotter, C., 2020. Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the Literature. Infect Dis Ther, v. 9
Doi: http://doi.org/10.1007/s40121-020-00291-9
2019 (Accepted for publication)
Arifin, SMN., Zimmer, C., Trotter, C., Colombini, A., Sidikou, F., LaForce, FM., Cohen, T. and Yaesoubi, R., 2019 (Accepted for publication). Cost-effectiveness of the alternative uses of polyvalent meningococcal vaccines in Niger: an agent-based transmission modeling study Medical Decision Making,
Cooper, LV., Kristiansen, PA., Christensen, H., Karachaliou, A. and Trotter, CL., 2019 (Accepted for publication). Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis. Epidemiol Infect, v. 147
Doi: http://doi.org/10.1017/S0950268819001134
Diallo, K., MacLennan, J., Harrison, O., Msefula, C., Sow, S., Daugla, D., Johnson, E., Trotter, C., MacLennan, C., Parkhill, J., Borrow, R., Greenwood, B. and Maiden, M., 2019 (Accepted for publication). Genomic characterization of novel Neisseria species Scientific Reports,
2019
Bratcher, HB., Rodrigues, CMC., Finn, A., Wootton, M., Cameron, JC., Smith, A., Heath, P., Ladhani, S., Snape, MD., Pollard, AJ., Cunningham, R., Borrow, R., Trotter, C., Gray, SJ., Maiden, MCJ. and MacLennan, JM., 2019. UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence. Wellcome Open Res, v. 4
Doi: http://doi.org/10.12688/wellcomeopenres.15362.2
Bratcher, HB., Rodrigues, CMC., Finn, A., Wootton, M., Cameron, JC., Smith, A., Heath, P., Ladhani, S., Snape, MD., Pollard, AJ., Cunningham, R., Borrow, R., Trotter, C., Gray, SJ., Maiden, MCJ. and MacLennan, JM., 2019. UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence. Wellcome open research, v. 4
Doi: http://doi.org/10.12688/wellcomeopenres.15362.2
Moura Silveira, M., McBride, AJA. and Trotter, CL., 2019. Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme. Vaccine, v. 37
Doi: http://doi.org/10.1016/j.vaccine.2019.09.062
Cooper, LV., Ronveaux, O., Fernandez, K., Lingani, C., Goumbi, K., Ihekweazu, C., Preziosi, M-P., Durupt, A. and Trotter, CL., 2019. Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response. J Infect Dis, v. 220
Doi: http://doi.org/10.1093/infdis/jiz343
Acevedo, R., Bai, X., Borrow, R., Caugant, DA., Carlos, J., Ceyhan, M., Christensen, H., Climent, Y., De Wals, P., Dinleyici, EC., Echaniz-Aviles, G., Hakawi, A., Kamiya, H., Karachaliou, A., Lucidarme, J., Meiring, S., Mironov, K., Sáfadi, MAP., Shao, Z., Smith, V., Steffen, R., Stenmark, B., Taha, M-K., Trotter, C., Vázquez, JA. and Zhu, B., 2019. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines, v. 18
Doi: http://doi.org/10.1080/14760584.2019.1557520
Cooper, LV., Robson, A., Trotter, CL., Aseffa, A., Collard, J-M., Daugla, DM., Diallo, A., Hodgson, A., Jusot, J-F., Omotara, B., Sow, S., Hassan-King, M., Manigart, O., Nascimento, M., Woukeu, A., Chandramohan, D., Borrow, R., Maiden, MCJ., Greenwood, B., Stuart, JM. and MenAfriCar Consortium, , 2019. Risk factors for acquisition of meningococcal carriage in the African meningitis belt. Trop Med Int Health,
Doi: http://doi.org/10.1111/tmi.13203
White, M., Idoko, O., Sow, S., Diallo, A., Kampmann, B., Borrow, R. and Trotter, C., 2019. Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials. Lancet Infect Dis, v. 19
Doi: http://doi.org/10.1016/S1473-3099(18)30674-1
Marshall, HS., McMillan, M., Koehler, A., Lawrence, A., MacLennan, J., Maiden, M., Ramsay, M., Ladhani, SN., Trotter, C., Borrow, R., Finn, A., Sullivan, T., Richmond, P., Kahler, C., Whelan, J. and Vadivelu, K., 2019. B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis. BMJ Open, v. 9
Doi: http://doi.org/10.1136/bmjopen-2018-027233
WHO Rabies Modelling Consortium, , 2019. Zero human deaths from dog-mediated rabies by 2030: perspectives from quantitative and mathematical modelling. Gates Open Res, v. 3
Doi: http://doi.org/10.12688/gatesopenres.13074.2
2018 (Accepted for publication)
Yaro, S., Njanpop Lafourcade, BM., Ouangraoua, S., Ouoba, AR., Kpoda, HBN., Findlow, H., Tall, H., Seanehia, J., Martin, C., Ouedraogo, JB., Gessner, BD., Meda, N., Borrow, R., Trotter, CL. and Mueller, J., 2018 (Accepted for publication). Antibody persistence at the population level 5 years after mass vaccination with meningococcal serogroup A conjugate vaccine (PsA-TT) in Burkina Faso: need for a booster campaign? Clinical Infectious Diseases,
Lasseter, G., Al-Janabi, H., Trotter, CL., Carroll, F. and Christensen, H., 2018 (Accepted for publication). The views of the general public on prioritising vaccination programmes against childhood diseases: A qualitative study PLoS ONE,
Gaythorpe, K., Trotter, CL. and Conlan, A., 2018 (Accepted for publication). Modelling norovirus transmission and vaccination Vaccine,
Trotter, CL. and Hampson, K., 2018 (Accepted for publication). The potential impact of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study The Lancet Infectious Diseases,
Giorgakoudi, K., O'Sullivan, C., Heath, P., Ladhani, S., Lamagni, T., Ramsay, M., al-Janabi, H. and Trotter, CL., 2018 (Accepted for publication). Cost-Effectiveness Analysis of Maternal Immunisation Against Group B Streptococcus (GBS) Disease: a Modelling Study. Vaccine,
2018
Daniel, P., Rodrigo, C., Bewick, T., Sheppard, C., Greenwood, S., McKeever, TM., Trotter, C. and Lim, WS., 2018. 13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups. Vaccine, v. 36
Doi: http://doi.org/10.1016/j.vaccine.2018.02.005
Marshall, HS., McMillan, M., Koehler, A., Lawrence, A., MacLennan, JM., Maiden, MCJ., Ramsay, M., Ladhani, SN., Trotter, C., Borrow, R., Finn, A., Sullivan, T., Richmond, P., Kahler, CM., Whelan, J. and Vadivelu, K., 2018. B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open, v. 8
Doi: http://doi.org/10.1136/bmjopen-2017-020988
Hampson, K., Abela-Ridder, B., Bharti, O., Knopf, L., Léchenne, M., Mindekem, R., Tarantola, A., Zinsstag, J. and Trotter, C., 2018. Modelling to inform prophylaxis regimens to prevent human rabies Vaccine,
Doi: http://doi.org/10.1016/j.vaccine.2018.11.010
Greenwood, BM., Aseffa, A., Caugant, DA., Diallo, K., Kristiansen, PA., Maiden, MCJ., Stuart, JM. and Trotter, CL., 2018. Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt. Trop Med Int Health,
Doi: http://doi.org/10.1111/tmi.13185
Diallo, K., Coulibaly, MD., Rebbetts, LS., Harrison, OB., Lucidarme, J., Gamougam, K., Tekletsion, YK., Bugri, A., Toure, A., Issaka, B., Dieng, M., Trotter, C., Collard, J-M., Sow, SO., Wang, X., Mayer, LW., Borrow, R., Greenwood, BM., Maiden, MCJ., Manigart, O. and MenAfriCar Consortium, , 2018. Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt. PLoS One, v. 13
Doi: http://doi.org/10.1371/journal.pone.0206453
Basta, NE., Berthe, A., Keita, M., Onwuchekwa, U., Tamboura, B., Traore, A., Hassan-King, M., Manigart, O., Nascimento, M., Stuart, JM., Trotter, C., Blake, J., Carr, AD., Gray, SJ., Newbold, LS., Deng, Y., Wolfson, J., Halloran, ME., Greenwood, B., Borrow, R. and Sow, SO., 2018. Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study. J Infect, v. 76
Doi: http://doi.org/10.1016/j.jinf.2017.11.006
2017 (Accepted for publication)
Cooper, LV., Stuart, JM., Okot, C., Asiedu-Bekoe, F., Afreh, OK., Fernandez, K., Ronveaux, O. and Trotter, CL., 2017 (Accepted for publication). Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: analysis of outbreak data from Ghana Vaccine,
Doi: http://doi.org/10.1016/j.vaccine.2017.12.069
Gaythorpe, KAM., Trotter, CL., Lopman, B., Steele, M. and Conlan, AJK., 2017 (Accepted for publication). Norovirus transmission dynamics: a modelling review Epidemiology and Infection,
Yaesoubi, R., Trotter, CL., Colijn, C., Yaesoubi, M., Colombini, A., Resch, S., Kristiansen, P., LaForce, M. and Cohen, T., 2017 (Accepted for publication). The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: a transmission dynamic modeling study PLoS Medicine,
2017
Trotter, CL., Lingani, C., Fernandez, K., Cooper, LV., Bita, A., Tevi-Benissan, C., Ronveaux, O., Préziosi, M-P. and Stuart, JM., 2017. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data Lancet Infectious Diseases, v. 17
Doi: http://doi.org/10.1016/S1473-3099(17)30301-8
Diallo, K., Gamougam, K., Daugla, DM., Harrison, OB., Bray, JE., Caugant, DA., Lucidarme, J., Trotter, CL., Hassan-King, M., Stuart, JM., Manigart, O., Greenwood, BM. and Maiden, MCJ., 2017. Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad. BMC Genomics, v. 18
Doi: http://doi.org/10.1186/s12864-017-3789-0
Cooper, LV., Boukary, RM., Borrow, R., Aseffa, A., Mihret, W., Collard, JM., Doumagoum, D., Hodgson, A., Sokhna, C., Omotar, B., Sow, S., Quaye, SL., Diallo, K., Manigart, O., Maiden, MCJ., Findlow, H., Borrow, R., Stuart, JM., Greenwood, BM. and Trotter, CL., 2017. Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt PLoS ONE,
Doi: http://doi.org/10.1371/journal.pone.0182575
Kohli-Lynch, M., Russell, NJ., Seale, AC., Dangor, Z., Tann, CJ., Baker, CJ., Bartlett, L., Cutland, C., Gravett, MG., Heath, PT., Ip, M., Le Doare, K., Madhi, SA., Rubens, CE., Saha, SK., Schrag, S., Sobanjo-Ter Meulen, A., Vekemans, J., O'Sullivan, C., Nakwa, F., Ben Hamouda, H., Soua, H., Giorgakoudi, K., Ladhani, S., Lamagni, T., Rattue, H., Trotter, C. and Lawn, JE., 2017. Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis, v. 65
Doi: http://doi.org/10.1093/cid/cix663
2016 (Accepted for publication)
Borrow, R., Alarcón, P., Carlos, J., Caugant, DA., Christensen, H., Debbag, R., De Wals, P., Echániz-Aviles, G., Findlow, J., Head, C., Holt, D., Kamiya, H., Saha, SK., Sidorenko, S., Taha, M-K., Trotter, C., Vázquez Moreno, JA., von Gottberg, A., Sáfadi, MAP. and on behalf of the Global Meningococcal Initiative, , 2016 (Accepted for publication). The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection Expert Review of Vaccines,
Doi: http://doi.org/10.1080/14760584.2017.1258308
2016
Al-Janabi, H., Van Exel, J., Brouwer, W., Trotter, C., Glennie, L., Hannigan, L. and Coast, J., 2016. Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis. Health Econ, v. 25
Doi: http://doi.org/10.1002/hec.3259
MenAfriCar Consortium, , 2016. Household transmission of $\textit{Neisseria meningitidis}$ in the African meningitis belt: a longitudinal cohort study The Lancet Global Health, v. 4
Doi: http://doi.org/10.1016/S2214-109X(16)30244-3
Manigart, O., Trotter, C., Findlow, H., Assefa, A., Mihret, W., Moti Demisse, T., Yeshitela, B., Osei, I., Hodgson, A., Quaye, SL., Sow, S., Coulibaly, M., Diallo, K., Traore, A., Collard, J-M., Moustapha Boukary, R., Djermakoye, O., Mahamane, AE., Jusot, J-F., Sokhna, C., Alavo, S., Doucoure, S., Ba, EH., Dieng, M., Diallo, A., Daugla, DM., Omotara, B., Chandramohan, D., Hassan-King, M., Nascimento, M., Woukeu, A., Borrow, R., Stuart, JM. and Greenwood, B., 2016. A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt. PLoS One, v. 11
Doi: http://doi.org/10.1371/journal.pone.0147928
Batista Ferrer, H., Trotter, CL., Hickman, M. and Audrey, S., 2016. Barriers and facilitators to uptake of the school-based HPV vaccination programme in an ethnically diverse group of young women. J Public Health (Oxf), v. 38
Doi: http://doi.org/10.1093/pubmed/fdv073
Diallo, K., Trotter, C., Timbine, Y., Tamboura, B., Sow, SO., Issaka, B., Dano, ID., Collard, J-M., Dieng, M., Diallo, A., Mihret, A., Ali, OA., Aseffa, A., Quaye, SL., Bugri, A., Osei, I., Gamougam, K., Mbainadji, L., Daugla, DM., Gadzama, G., Sambo, ZB., Omotara, BA., Bennett, JS., Rebbetts, LS., Watkins, ER., Nascimento, M., Woukeu, A., Manigart, O., Borrow, R., Stuart, JM., Greenwood, BM. and Maiden, MCJ., 2016. Pharyngeal carriage of Neisseria species in the African meningitis belt. J Infect, v. 72
Doi: http://doi.org/10.1016/j.jinf.2016.03.010
Christensen, H., Irving, T., Koch, J., Trotter, CL., Ultsch, B., Weidemann, F., Wichmann, O. and Hellenbrand, W., 2016. Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in Germany. Vaccine, v. 34
Doi: http://doi.org/10.1016/j.vaccine.2016.04.004
Manigart, O., Okeakpu, J., Odutola, A., Jarju, S., Foster-Nyarko, E., Diallo, K., Roca, A., Kampmann, B., D'Alessandro, U., Sow, S., Antonio, M., Maiden, MJ., Borrow, R., Stuart, JM., Trotter, CL. and Greenwood, BM., 2016. Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial Density. J Clin Microbiol, v. 54
Doi: http://doi.org/10.1128/JCM.01428-16
Manigart, O., Trotter, C., Findlow, H., Aseffa, A., Mihret, W., Moti Demisse, T., Yeshitela, B., Osei, I., Hodgson, A., Quaye, SL., Sow, S., Coulibaly, M., Diallo, K., Traore, A., Collard, J-M., Moustapha Boukary, R., Djermakoye, O., Mahamane, AE., Jusot, J-F., Sokhna, C., Alavo, S., Doucoure, S., Ba, EH., Dieng, M., Diallo, A., Daugla, DM., Omotara, B., Chandramohan, D., Hassan-King, M., Nascimento, M., Woukeu, A., Borrow, R., Stuart, JM. and Greenwood, B., 2016. Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt PLOS ONE, v. 11
Doi: http://doi.org/10.1371/journal.pone.0158938
2015
Trotter, CL., Cibrelus, L., Fernandez, K., Lingani, C., Ronveaux, O. and Stuart, JM., 2015. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®. Vaccine, v. 33
Doi: http://doi.org/10.1016/j.vaccine.2015.09.107
Karachaliou, A., Conlan, AJK., Preziosi, M-P. and Trotter, CL., 2015. Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt. Clin Infect Dis, v. 61 Suppl 5
Doi: http://doi.org/10.1093/cid/civ508
Tall, H., Yaro, S., Kpoda, HBN., Ouangraoua, S., Trotter, CL., Njanpop Lafourcade, B-M., Findlow, H., Bai, X., Martin, C., Nwakamma, I., Ouedraogo, JB., Gessner, BD., Borrow, R. and Mueller, JE., 2015. Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso. Clin Infect Dis, v. 61 Suppl 5
Doi: http://doi.org/10.1093/cid/civ519
Basta, NE., Borrow, R., Berthe, A., Onwuchekwa, U., Dembélé, ATE., Almond, R., Frankland, S., Patel, S., Wood, D., Nascimento, M., Manigart, O., Trotter, CL., Greenwood, B. and Sow, SO., 2015. Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali. Clin Infect Dis, v. 61 Suppl 5
Doi: http://doi.org/10.1093/cid/civ513
Colombini, A., Trotter, C., Madrid, Y., Karachaliou, A. and Preziosi, M-P., 2015. Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso. Clin Infect Dis, v. 61 Suppl 5
Doi: http://doi.org/10.1093/cid/civ600
Marlow, R., Ferreira, M., Cordeiro, E., Trotter, C., Januário, L., Finn, A. and Rodrigues, F., 2015. Case control study of rotavirus vaccine effectiveness in Portugal during 6 years of private market use. Pediatr Infect Dis J, v. 34
Doi: http://doi.org/10.1097/INF.0000000000000647
MenAfriCar consortium, , 2015. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine. J Infect Dis, v. 212
Doi: http://doi.org/10.1093/infdis/jiv211
Gamougam, K., Daugla, DM., Toralta, J., Ngadoua, C., Fermon, F., Page, A-L., Djingarey, MH., Caugant, DA., Manigart, O., Trotter, CL., Stuart, JM. and Greenwood, BM., 2015. Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. Emerg Infect Dis, v. 21
Doi: http://doi.org/10.3201/eid2101.140256
Marlow, R., Muir, P., Vipond, B., Lyttle, M., Trotter, C. and Finn, A., 2015. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom. Euro Surveill, v. 20
Doi: http://doi.org/10.2807/1560-7917.ES.2015.20.48.30077
Rodrigo, C., Bewick, T., Sheppard, C., Greenwood, S., Mckeever, TM., Trotter, CL., Slack, M., George, R. and Lim, WS., 2015. Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia. Eur Respir J, v. 45
Doi: http://doi.org/10.1183/09031936.00183614
Nicoli, EJ., Ayabina, D., Trotter, CL., Turner, KME. and Colijn, C., 2015. Competition, coinfection and strain replacement in models of Bordetella pertussis. Theor Popul Biol, v. 103
Doi: http://doi.org/10.1016/j.tpb.2015.05.003
Marlow, R., Ferreira, M., Cordeiro, E., Trotter, C., Januário, L., Finn, A. and Rodrigues, F., 2015. Case control study of rotavirus vaccine effectiveness in Portugal during 6 years of private market use Pediatric Infectious Disease Journal, v. 34
Doi: http://doi.org/10.1097/INF.0000000000000647
Nicoli, EJ., Ayabina, D., Trotter, CL., Turner, KME. and Colijn, C., 2015. Competition, coinfection and strain replacement in models of Bordetella pertussis Theoretical Population Biology, v. 103
Doi: http://doi.org/10.1016/j.tpb.2015.05.003
Batista Ferrer, H., Audrey, S., Trotter, C. and Hickman, M., 2015. An appraisal of theoretical approaches to examining behaviours in relation to Human Papillomavirus (HPV) vaccination of young women. Prev Med, v. 81
Doi: http://doi.org/10.1016/j.ypmed.2015.08.004
2014
Brehony, C., Trotter, CL., Ramsay, ME., Chandra, M., Jolley, KA., van der Ende, A., Carion, F., Berthelsen, L., Hoffmann, S., Harðardóttir, H., Vazquez, JA., Murphy, K., Toropainen, M., Caniça, M., Ferreira, E., Diggle, M., Edwards, GF., Taha, M-K., Stefanelli, P., Kriz, P., Gray, SJ., Fox, AJ., Jacobsson, S., Claus, H., Vogel, U., Tzanakaki, G., Heuberger, S., Caugant, DA., Frosch, M. and Maiden, MCJ., 2014. Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development. Clin Vaccine Immunol, v. 21
Doi: http://doi.org/10.1128/CVI.00133-14
Fisher, H., Audrey, S., Mytton, JA., Hickman, M. and Trotter, C., 2014. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. J Public Health (Oxf), v. 36
Doi: http://doi.org/10.1093/pubmed/fdt042
Ferraro, CF., Trotter, CL., Nascimento, MC., Jusot, J-F., Omotara, BA., Hodgson, A., Ali, O., Alavo, S., Sow, S., Daugla, DM. and Stuart, JM., 2014. Household crowding, social mixing patterns and respiratory symptoms in seven countries of the African meningitis belt. PLoS One, v. 9
Doi: http://doi.org/10.1371/journal.pone.0101129
Ferrer, HB., Trotter, C., Hickman, M. and Audrey, S., 2014. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health, v. 14
Doi: http://doi.org/10.1186/1471-2458-14-700
Christensen, H., Trotter, CL., Hickman, M. and Edmunds, WJ., 2014. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ, v. 349
Doi: http://doi.org/10.1136/bmj.g5725
Christensen, H., Trotter, CL., Hickman, M. and Edmunds, WJ., 2014. Authors' reply to Rappuoli and colleagues, Black, and Glennie and colleagues. BMJ, v. 349
Doi: http://doi.org/10.1136/bmj.g6758
Fisher, H., Audrey, S., Mytton, JA., Hickman, M. and Trotter, C., 2014. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study Journal of public health (Oxford, England), v. 36
Doi: http://doi.org/10.1093/pubmed/fdt042
Ladhani, SN., Cordery, R., Mandal, S., Christensen, H., Campbell, H., Borrow, R., Ramsay, ME. and PHE VaPIBI Forum Members, , 2014. Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(®)). J Infect, v. 69
Doi: http://doi.org/10.1016/j.jinf.2014.07.002
Rodrigo, C., Bewick, T., Sheppard, C., Greenwood, S., MacGregor, V., Trotter, C., Slack, M., George, R. and Lim, WS., 2014. Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status Thorax, v. 69
Doi: http://doi.org/10.1136/thoraxjnl-2013-203987
Rodrigo, C., Bewick, T., Sheppard, C., Greenwood, S., Trotter, C., Slack, M., George, R. and Lim, WS., 2014. Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia. Vaccine, v. 32
Doi: http://doi.org/10.1016/j.vaccine.2014.01.035
Daugla, DM., Gami, JP., Gamougam, K., Naibei, N., Mbainadji, L., Narbé, M., Toralta, J., Kodbesse, B., Ngadoua, C., Coldiron, ME., Fermon, F., Page, AL., Djingarey, MH., Hugonnet, S., Harrison, OB., Rebbetts, LS., Tekletsion, Y., Watkins, ER., Hill, D., Caugant, DA., Chandramohan, D., Hassan-King, M., Manigart, O., Nascimento, M., Woukeu, A., Trotter, C., Stuart, JM., Maiden, MCJ. and Greenwood, BM., 2014. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study The Lancet, v. 383
Doi: http://doi.org/10.1016/S0140-6736(13)61612-8
Rodrigo, C., Bewick, T., Sheppard, C., Greenwood, S., Trotter, C., Slack, M., George, R. and Lim, WS., 2014. Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia Vaccine, v. 32
Doi: http://doi.org/10.1016/j.vaccine.2014.01.035
2013
Fisher, H., Trotter, CL., Audrey, S., MacDonald-Wallis, K. and Hickman, M., 2013. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol, v. 42
Doi: http://doi.org/10.1093/ije/dyt049
Nicoli, EJ., Trotter, CL., Turner, KME., Colijn, C., Waight, P. and Miller, E., 2013. Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK Journal of Infection, v. 66
Doi: http://doi.org/10.1016/j.jinf.2013.02.007
Christensen, H., Hickman, M., Edmunds, WJ. and Trotter, CL., 2013. Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact Vaccine, v. 31
Doi: http://doi.org/10.1016/j.vaccine.2013.03.034
Borrow, R., Abad, R., Trotter, C., van der Klis, FRM. and Vazquez, JA., 2013. Effectiveness of meningococcal serogroup C vaccine programmes Vaccine,
Ali, O., Aseffa (PI), A., Bedru, A., Lemma, T., Moti, T., Worku, A., Xabher, HG., Yamuah, L., Boukary, RM., Collard (PI), J-M., Dano, ID., Habiboulaye, I., Issaka, B., Jusot, J-F., Ousmane, S., Rabe, I., Clark, T., Mayer, L., Gami, JP., Gamougam, K., Kodbesse, B., Naibei, N., Ngadoua, C., Mbainadji, L., Moto (PI), DD., Narbe, M., Toralta, J., Berthe, A., Keita, M., Diallo, K., Onwuchekwa, U., Sow (PI), SO., Tamboura, B., Traore, A., Toure, A., Amodu, M., Beida, O., Gadzama, G., Omotara (PI), B., Sambo, Z., Yahya, S., Chandramohan, D., Greenwood, B., Hassan-King, M., Manigart, O., Nascimento, M., Stuart, J., Woukeu, A., Bai, X., Borrow, R., Findlow, H., Avalo, S., Bassene, H., Diallo (PI), A., Dieng, M., Doucoure, S., Gomis, JF., Ndiaye, A., Sokhna, C., Trape, JF., Akalifa, B., Forgor, A., Hodgson (PI), A., Osei, I., Quaye, S., Williams, J., Wontuo, P., Basta, N., Irving, T., Trotter, C., Bennett, J., Dieng, M., Hill, D., Harrison, O., Rebbetts, L., Maiden, M., Tekletsion, Y. and Watkins, E., 2013. Meningococcal carriage in the African meningitis belt TROPICAL MEDICINE & INTERNATIONAL HEALTH, v. 18
Doi: http://doi.org/10.1111/tmi.12125
Borrow, R., Abad, R., Trotter, C., van der Klis, FRM. and Vazquez, JA., 2013. Effectiveness of meningococcal serogroup C vaccine programmes Vaccine, v. 31
Doi: http://doi.org/10.1016/j.vaccine.2013.07.083
Daugla, DM., Gami, JP., Gamougam, K., Naibei, N., Mbainadji, L., Narbé, M., Toralta, J., Kodbesse, B., Ngadoua, C., Coldiron, ME., Fermon, F., Page, A-L., Djingarey, MH., Hugonnet, S., Harrison, OB., Rebbetts, LS., Tekletsion, Y., Watkins, ER., Hill, D., Caugant, DA., Chandramohan, D., Hassan-King, M., Manigart, O., Nascimento, M., Woukeu, A., Trotter, C., Stuart, JM., Maiden, MCJ. and Greenwood, BM., 2013. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial The Lancet,
Bewick, T., Sheppard, C., Greenwood, S., Slack, M., Trotter, C., George, R. and Lim, WS., 2013. Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults European Respiratory Journal, v. 42
Doi: http://doi.org/10.1183/09031936.00144712
Rodrigo, C., Bewick, T., Sheppard, C., Greenwood, S., MacGregor, V., Trotter, C., Slack, M., George, R. and Lim, WS., 2013. Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status Thorax,
Clark, LJ., Glennie, L., Audrey, S., Hickman, M. and Trotter, CL., 2013. The health, social and educational needs of children who have survived meningitis and septicaemia: The parents' perspective BMC Public Health, v. 13
Doi: http://doi.org/10.1186/1471-2458-13-954
Loaring, J., Hickman, M., Oliver, I., Campbell, R., Trotter, C., Macleod, J., Pye, K., Crichton, J. and Horner, P., 2013. Could a peer-led intervention increase uptake of chlamydia screening? A proof of principle pilot study. J Fam Plann Reprod Health Care, v. 39
Doi: http://doi.org/10.1136/jfprhc-2011-100151
Basta, NE., Stuart, JM., Nascimento, MC., Manigart, O., Trotter, C., Hassan-King, M., Chandramohan, D., Sow, SO., Berthe, A., Bedru, A., Tekletsion, YK., Collard, JM., Jusot, JF., Diallo, A., Basséne, H., Daugla, DM., Gamougam, K., Hodgson, A., Forgor, AA., Omotara, BA., Gadzama, GB., Watkins, ER., Rebbetts, LS., Diallo, K., Weiss, NS., Halloran, ME., Maiden, MCJ. and Greenwood, B., 2013. Methods for Identifying Neisseria meningitidis Carriers: A Multi-Center Study in the African Meningitis Belt PLoS ONE, v. 8
Doi: http://doi.org/10.1371/journal.pone.0078336
Trotter, CL., Yaro, S., Njanpop-Lafourcade, B-M., Drabo, A., Kroman, SS., Idohou, RS., Sanou, O., Bowen, L., Findlow, H., Diagbouga, S., Gessner, BD., Borrow, R. and Mueller, JE., 2013. Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008. PLoS One, v. 8
Doi: http://doi.org/10.1371/journal.pone.0055486
Nicoli, EJ., Trotter, CL., Turner, KME., Colijn, C., Waight, P. and Miller, E., 2013. Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK. J Infect, v. 66
Doi: http://doi.org/10.1016/j.jinf.2013.02.007
Rodrigues, F., Foster, D., Nicoli, E., Trotter, C., Vipond, B., Muir, P., Goncalves, G., Januario, L. and Finn, A., 2013. Relationships Between Rhinitis Symptoms, Respiratory Viral Infections and Nasopharyngeal Colonization With <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i> and <i>Staphylococcus aureus</i> in Children Attending Daycare PEDIATRIC INFECTIOUS DISEASE JOURNAL, v. 32
Doi: 10.1097/INF.0b013e31827687fc
Christensen, H., Hickman, M., Edmunds, WJ. and Trotter, CL., 2013. Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact. Vaccine, v. 31
Doi: http://doi.org/10.1016/j.vaccine.2013.03.034
2012
Rozenbaum, MH., Van Hoek, AJ., Fleming, D., Trotter, CL., Miller, E. and Edmunds, WJ., 2012. Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: Economic analysis BMJ (Online), v. 345
Doi: http://doi.org/10.1136/bmj.e6879
Bewick, T., Sheppard, C., Greenwood, S., Slack, M., Trotter, C., George, R. and Lim, WS., 2012. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia Thorax, v. 67
Doi: http://doi.org/10.1136/thoraxjnl-2011-201092
van Hoek, AJ., Choi, YH., Trotter, C., Miller, E. and Jit, M., 2012. The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England. Vaccine, v. 30
Doi: http://doi.org/10.1016/j.vaccine.2012.10.017
Trotter, CL., Findlow, H. and Borrow, R., 2012. Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009. Clin Vaccine Immunol, v. 19
Doi: http://doi.org/10.1128/CVI.05515-11
Ishola, DA., Borrow, R., Findlow, H., Findlow, J., Trotter, C. and Ramsay, ME., 2012. Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction. Clin Vaccine Immunol, v. 19
Doi: http://doi.org/10.1128/CVI.05655-11
2011
Horner, P., Loaring, J., Matthew, H., Oliver, I., Campbell, R., Trotter, C., Macleod, J. and Pye, K., 2011. COULD A PEER DRIVEN INTERVENTION INCREASE UPTAKE OF CHLAMYDIA SCREENING? PROOF OF PRINCIPLE SEXUALLY TRANSMITTED INFECTIONS, v. 87
Doi: http://doi.org/10.1136/sextrans-2011-050108.251
2010
Christensen, H., May, M., Bowen, L., Hickman, M. and Trotter, CL., 2010. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis, v. 10
Doi: http://doi.org/10.1016/S1473-3099(10)70251-6
Campbell, H., Andrews, N., Borrow, R., Trotter, C. and Miller, E., 2010. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol, v. 17
Doi: http://doi.org/10.1128/CVI.00529-09
Trotter, CL., Waight, P., Andrews, NJ., Slack, M., Efstratiou, A., George, R. and Miller, E., 2010. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. J Infect, v. 60
Doi: http://doi.org/10.1016/j.jinf.2009.12.008
2009
Scott, P., Huss, A., Stuck, AE., Trotter, C. and Egger, M., 2009. Efficacy of pneumococcal polysaccharide vaccine CMAJ. Canadian Medical Association Journal, v. 180
Doi: http://doi.org/10.1503/cmaj.1090018
Huss, A., Scott, P., Stuck, AE., Trotter, C. and Egger, M., 2009. Efficacy of pneumococcal vaccination in adults: A meta-analysis CMAJ. Canadian Medical Association Journal, v. 180
Doi: http://doi.org/10.1503/cmaj.080734
Trotter, CL. and Maiden, MCJ., 2009. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines, v. 8
Doi: http://doi.org/10.1586/erv.09.48
2008
Trotter, CL., McVernon, J., Ramsay, ME., Whitney, CG., Mulholland, EK., Goldblatt, D., Hombach, J., Kieny, M-P. and SAGE subgroup, , 2008. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine, v. 26
Doi: http://doi.org/10.1016/j.vaccine.2008.05.073
Hussain, S., Gunnell, D., Donovan, J., Trotter, C., Verne, J., McPhail, S., Stephens, P. and Martin, R., 2008. Declining death rates for prostate cancer and trends of incidence and treatment in England and Wales (1975-2004): Is there a link? JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, v. 62
Hussain, S., Gunnell, D., Donovan, J., McPhail, S., Hamdy, F., Neal, D., Albertsen, P., Verne, J., Stephens, P., Trotter, C. and Martin, RM., 2008. Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU Int, v. 101
Doi: http://doi.org/10.1111/j.1464-410X.2007.07338.x
Trotter, CL., Borrow, R., Findlow, J., Holland, A., Frankland, S., Andrews, NJ. and Miller, E., 2008. Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era CLIN VACCINE IMMUNOL, v. 15
Doi: http://doi.org/10.1128/CVI.00279-08
Trotter, C., Scott, P., Huss, A. and Egger, M., 2008. Pneumococcal polysaccharide vaccine effectiveness: study quality must not be ignored The Lancet Infectious Diseases, v. 8
Doi: http://doi.org/10.1016/S1473-3099(08)70239-1
Thomas, HL., Andrews, N., Trotter, C., Ramsay, M. and Miller, E., 2008. Seroprotection and meningitis C: Meningococcal C booster not recommended by evidence BMJ, v. 337
Thomas, HL., Andrews, N., Trotter, C., Ramsay, M. and Miller, E., 2008. Meningococcal C booster not recommended by evidence. BMJ, v. 337
Doi: http://doi.org/10.1136/bmj.a1139
2007
Trotter, CL. and Ramsay, ME., 2007. Vaccination against meningococcal disease in Europe: Review and recommendations for the use of conjugate vaccines FEMS Microbiology Reviews, v. 31
Doi: http://doi.org/10.1111/j.1574-6976.2006.00053.x
Trotter, CL., Chandra, M., Cano, R., Larrauri, A., Ramsay, ME., Brehony, C., Jolley, KA., Maiden, MCJ., Heuberger, S. and Frosch, M., 2007. A surveillance network for meningococcal disease in Europe FEMS Microbiology Reviews, v. 31
Doi: http://doi.org/10.1111/j.1574-6976.2006.00060.x
Trotter, C., Findlow, J., Balmer, P., Holland, A., Barchha, R., Hamer, N., Andrews, N., Miller, E. and Borrow, R., 2007. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitildis group B in England CLIN VACCINE IMMUNOL, v. 14
Doi: http://doi.org/10.1128/CVI.00102-07
Maxwell, R., Trotter, C., Verne, J., Brown, P. and Gunnell, D., 2007. Trends in admissions to hospital involving an assault using a knife or other sharp instrument, England, 1997-2005. J Public Health (Oxf), v. 29
Doi: http://doi.org/10.1093/pubmed/fdm018
Irish, C., Maxwell, R., Dancox, M., Brown, P., Trotter, C., Verne, J. and Shaw, M., 2007. Skin and soft tissue infections and vascular disease among drug users, England [3] Emerging Infectious Diseases, v. 13
Doi: http://doi.org/10.3201/eid1310.061196
2006
Trotter, CL. and Edmunds, WJ., 2006. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Making, v. 26
Doi: http://doi.org/10.1177/0272989X05284109
Trotter, CL., Ramsay, ME., Gray, S., Fox, A. and Kaczmarski, E., 2006. No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales Lancet Infectious Diseases, v. 6
Doi: http://doi.org/10.1016/S1473-3099(06)70584-9
Trotter, CL., Edmunds, WJ., Ramsay, ME. and Miller, E., 2006. Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales Human Vaccines, v. 2
Doi: http://doi.org/10.4161/hv.2.2.2611
Gray, SJ., Trotter, CL., Ramsay, ME., Guiver, M., Fox, AJ., Borrow, R., Mallard, RH. and Kaczmarski, EB., 2006. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol, v. 55
Doi: http://doi.org/10.1099/jmm.0.46288-0
Gray, SJ., Trotter, CL., Ramsay, ME., Guiver, M., Fox, AJ., Borrow, R., Mallard, RH. and Kaczmarski, EB., 2006. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: Contribution and experiences of the Meningococcal Reference Unit Journal of Medical Microbiology, v. 55
Doi: http://doi.org/10.1099/jmm.0.46288-0
2005
Trotter, C., Samuelsson, S., Perrocheau, A., de Greeff, S., de Melker, H., Heuberger, S. and Ramsay, M., 2005. Ascertainment of meningococcal disease in Europe. Euro Surveill, v. 10
Doi: http://doi.org/10.2807/esm.10.12.00586-en
Welte, R., Trotter, CL., Edmunds, WJ., Postma, MJ. and Beutels, P., 2005. The role of economic evaluation in vaccine decision making: Focus on meningococcal group C conjugate vaccine PharmacoEconomics, v. 23
Doi: http://doi.org/10.2165/00019053-200523090-00001
Trotter, C., Samuelsson, S., Perrocheau, A., de Greeff, S., de Melker, H., Heuberger, S. and Ramsay, M., 2005. Ascertainment of meningococcal disease in Europe. Euro Surveill, v. 10
Pitman, RJ., Cooper, BS., Trotter, CL., Gay, NJ. and Edmunds, WJ., 2005. Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ, v. 331
Doi: http://doi.org/10.1136/bmj.38573.696100.3A
Trotter, CL., Gay, NJ. and Edmunds, WJ., 2005. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol, v. 162
Doi: http://doi.org/10.1093/aje/kwi160
2004
McVernon, J., Trotter, CL., Slack, MPE. and Ramsay, ME., 2004. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ, v. 329
Doi: http://doi.org/10.1136/bmj.329.7467.655
Trotter, CL., Andrews, NJ., Kaczmarski, EB., Miller, E. and Ramsay, ME., 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet, v. 364
Doi: http://doi.org/10.1016/S0140-6736(04)16725-1
2003
Trotter, CL. and Gay, NJ., 2003. Analysis of longitudinal bacterial carriage studies accounting for sensitivity of swabbing: an application to Neisseria meningitidis. Epidemiol Infect, v. 130
Doi: http://doi.org/10.1017/s0950268802008130
Trotter, C., Borrow, R., Andrews, N. and Miller, E., 2003. Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era. Vaccine, v. 21
Doi: http://doi.org/10.1016/s0264-410x(02)00630-8
Trotter, CL., Ramsay, ME. and Slack, MPE., 2003. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health, v. 6
Ramsay, ME., Andrews, NJ., Trotter, CL., Kaczmarski, EB. and Miller, E., 2003. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ, v. 326
Doi: http://doi.org/10.1136/bmj.326.7385.365
Trotter, CL., McVernon, J., Andrews, NJ., Burrage, M. and Ramsay, ME., 2003. Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet, v. 361
Doi: http://doi.org/10.1016/s0140-6736(03)13172-8
2002
Trotter, CL., Fox, AJ., Ramsay, ME., Sadler, F., Gray, SJ., Mallard, R. and Kaczmarski, EB., 2002. Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol, v. 51
Doi: http://doi.org/10.1099/0022-1317-51-10-855
Davison, KL., Ramsay, ME., Crowcroft, NS., Lieftucht, A., Kaczmarski, EB., Trotter, CL., Gungabissoon, U. and Begg, NT., 2002. Estimating the burden of serogroup C meningococcal disease in England and Wales. Commun Dis Public Health, v. 5
Trotter, CL., Ramsay, ME. and Kaczmarski, EB., 2002. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health, v. 5
Trotter, CL. and Edmunds, WJ., 2002. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ, v. 324
Doi: http://doi.org/10.1136/bmj.324.7341.809
